{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T13:54:11Z","timestamp":1794405251887,"version":"4.9.0"},"reference-count":104,"publisher":"SAGE Publications","issue":"3_suppl","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","award":["University of Auckland"],"award-info":[{"award-number":["University of Auckland"]}],"id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021732","name":"Aotearoa Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>Parkinson's disease (PD) is the fastest growing neurological condition worldwide with its prevalence set to double by 2050. With no cure in sight, management has turned to lifestyle modification, in particular to diet and exercise. The disease-modifying potential of dietary approaches has been of recent interest, particularly given emerging links between diet and reductions in systemic inflammation, oxidative stress, and alterations in the gut microbiome composition, all of which may modulate neurodegeneration. This review summarises the current \u2018state of the science\u2019 of dietary supplements in modifying disease progression through a lens of the pathophysiological hallmarks of PD. Biomarkers and clinical outcomes that serve as proxy measurements for disease modification are examined, whilst looking ahead at which dietary supplements show the most promise and should be the focus of future research.<\/jats:p>","DOI":"10.1177\/1877718x261446386","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:14:48Z","timestamp":1778685288000},"page":"50-63","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Dietary supplements for Parkinson's disease: State of the science"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5090-4173","authenticated-orcid":false,"given":"Aakash","family":"Prasad","sequence":"first","affiliation":[{"name":"Liggins Institute, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5062-3503","authenticated-orcid":false,"given":"Marshal Spenser","family":"Shuler","sequence":"additional","affiliation":[{"name":"Liggins Institute, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richelle","family":"Flanagan","sequence":"additional","affiliation":[{"name":"My Moves Matter, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswas","family":"Dayal","sequence":"additional","affiliation":[{"name":"Neurology Department, Auckland City Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona E","family":"Lithander","sequence":"additional","affiliation":[{"name":"Liggins Institute, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00116-9"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-322338"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00684-6"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-022-00681-2"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00560"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440726"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136416"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2021.09.006"},{"key":"e_1_3_2_10_2","article-title":"Special issue: non-pharmacological interventions for people with Parkinson's disease: are we entering a new era?","volume":"14","author":"Kalbe E","year":"2024","unstructured":"Kalbe E, Bloem BR, Kalia LV, et al. Special issue: non-pharmacological interventions for people with Parkinson's disease: are we entering a new era? J Parkinsons Dis 2024; 14: S1\u2013S4.","journal-title":"J Parkinsons Dis"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(25)00305-9"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70381"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293826"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-332974"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu17071169"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00681-7"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18178897"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20902"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1581590"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20213"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100997"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutos.2024.03.007"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/1028415X.2020.1735143"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.03.008"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.baga.2014.03.004"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106954"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2017.03.014"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2018.12.006"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/21.204"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.02.001"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43514-6"},{"key":"e_1_3_2_33_2","article-title":"Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial","volume":"7","author":"Yulug B","year":"2025","unstructured":"Yulug B, Altay O, Li X, et al. Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial. Brain Commun 2025; 7: fcae478.","journal-title":"Brain Commun"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22866"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1159\/000333790"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.667032"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu14061220"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007858"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.112.051664"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12476"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210200"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1017\/jns.2021.100"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301213280305"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-011-0877-3"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-008-8053-y"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000238518.34389.12"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000201252.57661.e1"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.120"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10040520"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12060975"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.10.1541"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(03)00185-X"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.7.nct60005"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000250355.28474.8e"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.05.022"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.131"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2013.5801"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27372"},{"key":"e_1_3_2_59_2","volume-title":"Parkinson's disease in adults: diagnosis and management: Full Guideline","author":"National Institute for Health Care Excellence","year":"2017","unstructured":"National Institute for Health Care Excellence. Parkinson's disease in adults: diagnosis and management: Full Guideline. National Institute for Health and Care Excellence, 2017."},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.5528"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.10207"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu17172884"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2022.107300"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00156-z"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2025.07.003"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03374-w"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00025"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1348279"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15671"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1017\/s0029665125101213"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.578386"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.70047"},{"key":"e_1_3_2_73_2","first-page":"289","article-title":"The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson's disease: a randomized, double-blind, PlaceboControlled trial","volume":"21","author":"Borzabadi S","year":"2018","unstructured":"Borzabadi S, Oryan S, Eidi A, et al. The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson's disease: a randomized, double-blind, PlaceboControlled trial. Arch Iran Med 2018; 21: 289\u2013295.","journal-title":"Arch Iran Med"},{"key":"e_1_3_2_74_2","article-title":"Effect of probiotics on MDS UPDRS in Parkinson disease at 12 weeks: a randomized double-blind placebo-controlled trial [abstract]","volume":"36","author":"George G","year":"2021","unstructured":"George G, Iype T. Effect of probiotics on MDS UPDRS in Parkinson disease at 12 weeks: a randomized double-blind placebo-controlled trial [abstract]. Mov Disord 2021; 36: S174.","journal-title":"Mov Disord"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-024-06606-9"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70541"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1039\/D3FO00728F"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-023-03910-w"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2022.105397"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-01752-8"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14111147"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74400-w"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00327-6"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.02.002"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1007654"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.937555"},{"key":"e_1_3_2_87_2","article-title":"Strain-specificity and disease-specificity of probiotic efficacy: A systematic review and meta-Analysis","volume":"5","author":"McFarland LV","year":"2018","unstructured":"McFarland LV, Evans CT, Goldstein EJC. Strain-specificity and disease-specificity of probiotic efficacy: A systematic review and meta-Analysis. Front Med (Lausanne) 2018; 5(, Systematic Review.","journal-title":"Front Med (Lausanne)"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu16162791"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.001377"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27790"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0061-2"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2017.58"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.57"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092057"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu14224886"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering12020208"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1080\/1028415X.2025.2469170"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2020.100037"},{"key":"e_1_3_2_99_2","first-page":"100172","article-title":"Therapeutic potential of baicalein against neurodegenerative diseases: an updated review","volume":"11","author":"Siddiqui N","year":"2024","unstructured":"Siddiqui N, Talib M, Tripathi PN, et al. Therapeutic potential of baicalein against neurodegenerative diseases: an updated review. Health Sci Rev 2024; 11: 100172.","journal-title":"Health Sci Rev"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2017.4078"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13691"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.2174\/1871527320666210506185042"},{"key":"e_1_3_2_103_2","doi-asserted-by":"crossref","unstructured":"Olanow CW Rascol O Hauser R et al. A double-blind delayed-start trial of Rasagiline in Parkinson's disease. 2009; 361: 1268\u20131278.","DOI":"10.1056\/NEJMoa0809335"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22402"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033447"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261446386","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X261446386","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261446386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T13:14:28Z","timestamp":1794402868000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X261446386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":104,"journal-issue":{"issue":"3_suppl","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1177\/1877718X261446386"],"URL":"https:\/\/doi.org\/10.1177\/1877718x261446386","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]}}}